Evidence map›Paper›PMID 34818070›Full record

ArticleJournal of virology2022

Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy.

Chunxiu Wu, Yizi He, Jin Zhao, Kun Luo, Ziyu Wen, Yudi Zhang, Minchao Li, Yilan Cui, Zijian Liu, Congcong Wang and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The role of latency reversal in HIV cure strategies.Journal of medical primatology · 2022
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Chunxiu Wu *State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Healthgrid.428926.3 (GIBH), Chinese Academy of Sciences, Guangzhou, China.
Yizi He *State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Healthgrid.428926.3 (GIBH), Chinese Academy of Sciences, Guangzhou, China.
Jin Zhao *School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
Kun LuoState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Healthgrid.428926.3 (GIBH), Chinese Academy of Sciences, Guangzhou, China.
Ziyu WenSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
Yudi ZhangState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Healthgrid.428926.3 (GIBH), Chinese Academy of Sciences, Guangzhou, China.
Minchao LiSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
Yilan CuiState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Healthgrid.428926.3 (GIBH), Chinese Academy of Sciences, Guangzhou, China.
Zijian LiuState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Healthgrid.428926.3 (GIBH), Chinese Academy of Sciences, Guangzhou, China.
Congcong WangSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
Zirong HanSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
Guangye LiGuangdong Landau Biotechnology Co. Ltd., Guangzhou, China.
Fengling FengSchool of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
Pingchao LiState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Healthgrid.428926.3 (GIBH), Chinese Academy of Sciences, Guangzhou, China.
Ling ChenState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Healthgrid.428926.3 (GIBH), Chinese Academy of Sciences, Guangzhou, China.ORCID 0000-0003-1485-1626
Caijun SunState Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Healthgrid.428926.3 (GIBH), Chinese Academy of Sciences, Guangzhou, China.ORCID 0000-0002-2000-7053
Chinese Academy of Sciences · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The persistence of cells latently infected with HIV-1, named the latent reservoir, is the major barrier to HIV-1 eradication, and the formation and maintenance of the latent reservoir might be exacerbated by activation of the immunoinhibitory pathway and dysfunction of CD8

Indexed as

AnimalsAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveBiopsyComputational BiologyDisease ProgressionImmunohistochemistryImmunomodulationMacaca mulattaProgrammed Cell Death 1 ReceptorSAIDS VaccinesSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusT-Lymphocyte SubsetsTranscriptomeViral LoadAnti-Retroviral AgentsProgrammed Cell Death 1 ReceptorSAIDS VaccinesHIVlatent viral reservoirprogrammed cell death protein 1 (PD-1) blockaderhesus macaquesSIVtherapeutic vaccination

Identifiers

PMID34818070
PMCPMC8827032
OpenAlexW3216798781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.